BioVersys AG (SWX:BIOV)
Switzerland · Delayed Price · Currency is CHF 27.20
+0.30 (1.12%)
Last updated: May 13, 2026, 12:16 PM CET
BioVersys AG Market Cap
BioVersys AG has a market cap or net worth of 157.31 million as of May 13, 2026. Its market cap has decreased by -22.60% in one year.
Market Cap
157.31M
Enterprise Value
96.54M
Revenue
3.18M
Ranking
n/a
PE Ratio
n/a
Stock Price
27.20
Market Cap Chart
Since February 6, 2025, BioVersys AG's market cap has decreased from 207.92M to 157.31M, a decrease of -24.34%. That is a compound annual growth rate of -19.85%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 12, 2026 | 157.31M | 10.25% |
| Dec 30, 2025 | 142.69M | -31.37% |
| Feb 6, 2025 | 207.92M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Bachem Holding AG | 5.93B |
| Idorsia | 1.01B |
| Basilea Pharmaceutica AG | 677.27M |
| Newron Pharmaceuticals | 283.01M |
| Santhera Pharmaceuticals Holding AG | 241.01M |
| Xlife Sciences AG | 121.12M |
| Molecular Partners AG | 118.97M |
| MindMaze Therapeutics Holding | 53.87M |